Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zahid Amin

Interventional Cardiology Orlando, FL Medical Doctor

NPI 1285639435 CMS profile 58469

2501 N Orange Ave Ste 209, # 8300, Orlando, FL 32804

Open in the dashboard

General payments

$634,811

798 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$34,866 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Zahid Amin of Orlando, FL is reported in the CMS Open Payments database as having received $634,811 across 798 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $34,866 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $45,894 57
2024 General $85,398 100
2023 General $139,833 172
2022 General $63,531 90
2021 General $32,239 48
2020 General $111,658 121
2019 General $156,257 210

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zahid Amin
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Zahid Amin were reported at $45,894. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Zahid Amin Interventional Cardiology median Middle half National median
2019 $156,257 $1,097 $329–$3,048 $163
2020 $111,658 $473 $161–$1,480 $114
2021 $32,239 $677 $233–$1,827 $132
2022 $63,531 $978 $333–$2,724 $149
2023 $139,833 $1,136 $382–$2,986 $160
2024 $85,398 $1,181 $395–$3,326 $164
2025 $45,894 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $396,921 453 payments
  2. Edwards Lifesciences Corporation $212,910 261 payments
  3. Philips Electronics North America Corporation $10,512 12 payments
  4. Medtronic, Inc. $9,172 39 payments
  5. Occlutech US LLC $2,250 1 payment
  6. Siemens Medical Solutions USA, Inc. $1,175 11 payments
  7. W. L. Gore & Associates, Inc. $872 9 payments
  8. Merit Medical Systems Inc $372 2 payments
  9. B. Braun Interventional Systems Inc. $272 3 payments
  10. Medtronic Vascular, Inc. $124 2 payments
  11. Other $231 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $412,855 104 payments
  2. Travel and Lodging $111,439 386 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $37,213 16 payments
  4. Honoraria $26,006 9 payments
  5. Food and Beverage $18,163 274 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $14,885 4 payments
  7. Compensation for serving as faculty or as a speaker for a medical education program $13,000 4 payments
  8. Education $1,250 1 payment
Products named General payments · program years 2019–2025
  1. AMPLATZER Occluders Cardiac Arrhythmias and Heart Failure $183,604 177 payments
  2. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $149,532 144 payments
  3. AMPLATZER Structural Heart $55,525 69 payments
  4. Edwards SAPIEN 3 Transcatheter Heart Valve $51,213 89 payments
  5. AMPLATZER PICCOLO $44,236 52 payments
  6. AMPLATZER AMULET $39,151 28 payments
  7. AMPLATZER Occluders Structural Heart $30,639 33 payments
  8. AMPLATZER Structural Heart $17,044 28 payments
  9. Cardiovascular- Research only $10,796 29 payments
  10. Edwards SAPIEN XT Transcatheter Heart Valve $10,374 11 payments
  11. Other $39,538 129 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$13,347

Medicare's payments for the services billed

Medicare patients

20

Average age 55

Services billed

128

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

798 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record